Director, Public Affairs, Global COVID-19 and Emerging Viruses Communications Lead

Foster City, CA
Oct 08, 2021
Required Education
Bachelors Degree
Position Type
Full time
Director, Public Affairs, Global COVID-19 and Emerging Viruses Communications Lead
United States - California - Foster City

Gilead Sciences, Inc. is a research-based bio-pharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. With each new discovery and investigational drug candidate, we seek to improve the care of patients living with life-threatening diseases around the world. Gilead’s therapeutic areas of focus include HIV/AIDS, liver diseases, cancer and inflammation, and serious respiratory and cardiovascular conditions.

Making an impact on a global scale
Inclusion is one of the company’s five core values. That’s because we know that we are stronger and more innovative at Gilead when we are informed by a diverse set of backgrounds, experiences and points of view. Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide.

When you join Gilead, you join our mission to change the world by enabling people to live healthier and more fulfilling lives. Come join a mission-driven bio-pharmaceutical organization that values inclusion and diversity, has a strong portfolio of products, and is constantly #CreatingPossible

This role will lead global communications for Gilead's COVID-19 antiviral, with a particular focus on coordination outside of the U.S. While COVID-19 vaccines are helping to bring much needed relief to communities around the world, effective therapeutics will continue to be a critical tool for healthcare providers to address ongoing infections. Reporting to the Executive Director of Public Affairs, Virology, this newly created position will be responsible for proactively shaping understanding of Gilead's COVID-19 antiviral and Gilead's commitment to therapeutics development for emerging viruses.

This role will play a pivotal part in driving understanding of the value of our antiviral in helping hospitalized patients recover more quickly from COVID-19 in this rapidly evolving disease area. Given the highly visible nature of the pandemic and the continued focus across Gilead and across the media, this role will engage a broad range of external stakeholders and internal teams to support communication of our comprehensive efforts to tackle the pandemic. In this fast-paced environment, this individual will drive best-practice sharing between countries and support cross-functional partners to drive excellence in communications strategy and tactical implementation.

Responsibilities Include:

  • Drive global alignment across communications with brand strategy and messaging, through coordination and partnership of in-country Public Affairs teams.
  • Provide communications counsel and engage with colleagues in Commercial, Medical Affairs, Clinical and Pre-clinical research, Government Affairs, Regulatory Affairs, and Legal as part of key cross-functional workstreams to drive strategy and tactical plans that shape understanding of the value of antiviral treatment and Gilead's comprehensive efforts to address the COVID-19 pandemic.
  • Lead proactive data communications for Veklury at key ex-U.S. infectious disease congresses, and support data communications from numerous collaborators around the world.
  • In partnership with the Global Commercial Product Strategy Team, coordinate cross-functional efforts to horizon scan and proactively address emerging issues.
  • Inform priorities and collaborate with regional Public Affairs leads including in Europe and Intercontinental regions, the U.S. COVID-19 communications lead, and other Public Affairs centers of expertise, including corporate communications, community engagement and corporate giving.
  • Develop materials to support external communications, including key messages, Q&A documents, press releases, presentations, videos, social media content, etc.
  • Provide rapid response to inquiries and maintain relationships with key top-tier international, trade and wire reporters to shape reporting on Veklury across a broad range of markets.
  • Manage global PR agency partners, providing agency teams with appropriate information and oversight to effectively implement programs in compliance with Gilead's business conduct policies.
  • Manage budgets to target, ensuring appropriate investment in priority work and identifying ways to optimize resources.

Knowledge, Experience and Skills:
  • BA Degree in Communications, Liberal Arts, Business or science-oriented field and 12+ years of relevant experience in healthcare communications or Master's Degree with 10 years of relevant experience.
  • Demonstrated experience driving communications plans that support business priorities.
  • Expertise in media relations and issues management.
  • Ability to interact with senior internal leaders, academic experts and patient advocates appropriately.
  • Ability to influence others and drive alignment across diverse teams.
  • A passion for engaging in public health and policy issues with an understanding of the European and Asian regulatory environments. Understanding of market access across key countries in Europe and Asia is preferred.
  • Adept at understanding scientific data. Prior experience in infectious disease communications is preferred.
  • Ability to deliver formal presentations to external and internal audiences of a variety of sizes.
  • Demonstrated knowledge of regulations governing communications for a publicly-traded biopharmaceutical company.

For jobs in the United States:

As an equal opportunity employer, Gilead Sciences Inc. is committed to a diverse workforce. Employment decisions regarding recruitment and selection will be made without discrimination based on race, color, religion, national origin, gender, age, sexual orientation, physical or mental disability, genetic information or characteristic, gender identity and expression, veteran status, or other non-job related characteristics or other prohibited grounds specified in applicable federal, state and local laws. In order to ensure reasonable accommodation for individuals protected by Section 503 of the Rehabilitation Act of 1973, the Vietnam Era Veterans\' Readjustment Act of 1974, and Title I of the Americans with Disabilities Act of 1990, applicants who require accommodation in the job application process may contact for assistance.

Following extensive monitoring, research, consideration of business implications and advice from internal and external experts, Gilead has made the decision to require all U.S. employees and contractors to receive the COVID-19 vaccines as a condition of employment. “Full vaccination” is defined as two weeks after both doses of a two-dose vaccine or two weeks since a single-dose vaccine has been administered. Anyone unable to be vaccinated, either because of a sincerely held religious belief or a medical condition or disability that prevents them from being vaccinated, can request a reasonable accommodation.\u200b

For more information about equal employment opportunity protections, please view the ‘EEO is the Law' poster.



Our environment respects individual differences and recognizes each employee as an integral member of our company. Our workforce reflects these values and celebrates the individuals who make up our growing team.

Gilead provides a work environment free of harassment and prohibited conduct. We promote and support individual differences and diversity of thoughts and opinion.

For Current Gilead Employees and Contractors:

Please log onto your Internal Career Site to apply for this job.